KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients
-
Published:2020-06-25
Issue:12
Volume:99
Page:2903-2909
-
ISSN:0939-5555
-
Container-title:Annals of Hematology
-
language:en
-
Short-container-title:Ann Hematol
Author:
Palmieri SalvatoreORCID, Rocco S., Vitagliano O., Catalano L., Cerchione C., Vincelli I. D., Scopelliti A., Gentile M., Farina G., Barone M., Gagliardi A., Esposito D., Arcamone M., Amico V., Fontana R., Sementa A., Sica A., Svanera G., Pane F., Ferrara F.
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference23 articles.
1. Jagannath S, Abonour R, Durie BGM, Gasparetto C, Hardin JW, Narang M, Terebelo HR, Toomey K, Wagner L, Srinivasan S, Kitali A, Yue L, Flick ED, Agarwal A, Rifkin RM (2018) Heterogeneity of second-line treatment for patients with multiple myeloma in the connect MM registry (2010-2016). Clin Lymphoma Myeloma Leuk 18(7):480–485 2. Anderson KC (2016) Progress and paradigms in multiple myeloma. Clin Cancer Res 22(22):5419–5427 3. Agarwal A, Chow E, Bhutani M, Voorhees PM, Friend R, Usmani SZ (2017) Practical considerations in managing relapsed multiple myeloma. Clin Lymphoma Myeloma Leuk 17(2):69–77 4. Mohty M, Terpos E, Mateos MV, Cavo M, Lejniece S, Beksac M, Bekadja MA, Legiec W, Dimopoulos M, Stankovic S, Durán MS, de Stefano V, Corso A, Kochkareva Y, Laane E, Berthou C, Salwender H, Masliak Z, Pečeliūnas V, Willenbacher W, Silva J, Louw V, Nemet D, Borbényi Z, Abadi U, Pedersen RS, Černelč P, Potamianou A, Couturier C, Feys C, Thoret-Bauchet F, Boccadoro M, Bekadja M, Hamladji RM, Ali HA, Hamdi S, Touhami H, Mansour NS, Willenbacher W, Linkesch W, Nemet D, Pedersen RS, Abildgaard N, Laane E, Hein M, Mohty M, Eveillard JR, Yamani A, Moreau P, Sanhes L, Lepeu G, Laribi K, Jourdan E, Fitoussi O, Allangba O, Fleury J, Escoffre M, Benramdane R, Cartron G, Dine G, Legouffe E, Harich HD, Illmer T, Dörfel S, Hannig CV, Koenigsmann M, Prange-Krex G, Salwender H, Tamm I, Zeller W, Maasberg M, Schlag R, Klausmann M, Uhlig J, Alkemper B, Schütz S, Tessen HW, Mohr B, Schmidt P, Heinrich B, Hebart H, Seipelt G, Zoeller T, Heits F, Müller-Naendrup C, Hansen R, Repp R, von Weikersthal LF, Schmits R, Heßling J, Krammer-Steiner B, Janzen V, Schauer M, Grüner MW, Kisro J, Denzlinger C, Freier W, Junghanss C, Görner M, Laichinger K, Ostermann H, Dürk H, Hess G, Reich G, Terpos E, Dimopoulos M, Matsouka P, Pouli A, Anagnostopoulos A, Masszi T, Borbényi Z, Ivanyi J, Szomor A, Abadi U, Nagler A, Magen H, Avivi I, Quitt M, Palumbo A, Boccadoro M, de Stefano V, Za T, Vallisa D, Foa R, Corso A, Bosi A, Vacca A, Lanza F, Palazzo G, Avvisati G, Cavo M, Ferrara F, Consoli U, Cantonetti M, Angelucci E, Califano C, di Raimondo F, Guarini A, Musso M, Pizzuti M, Giuliani N, Ardizzoia A, di Renzo N, Gaidano G, Gozzetti A, Pitini V, Farina G, Centurioni R, de Fabritiis P, Iuliano F, la Nasa G, la Verde G, Pane F, Recine U, la Targia M, Mineo G, Cangialosi C, Fagnani D, Federici A, Romano A, Specchia G, Storti S, Bongarzoni V, Bacigalupo A, Gobbi M, Latte G, Mannina D, Capalbo S, Lejniece S, Pečeliūnas V, Jurgutis M, Stankovic S, Legiec W, Woszczyk D, Hołojda J, Gornik S, Pluta A, Morawiec-Szymonik E, Kyrcz-Krzemien S, Homenda W, Grosicki S, Sulek K, Lange A, Kloczko J, Starzak-Gwozdz J, Hellmann A, Komarnicki M, Kuliczkowski K, Viveiros C, Gonçalves C, Esefyeva N, Kochkareva J, Kaplanov K, Volodicheva E, Laricheva E, Dergacheva V, Chukavina M, Volchenko N, Nazarova I, Anchukova L, Ovanesova E, Gritsenko T, Salogub G, Magomedova L, Kuznetsova I, Osyunikhina S, Serdyuk O, Karyagina E, Ivanova V, Černelč SP, Louw V, Coetzee C, Gunther K, Moodley D, Duran S, Gutiérrez AE, de Oteyza JP, Capote FJ, Casanova M, Sanchez JM, Rios-Herranz E, Ibañez-Garcia J, Herranz MJ, Hernandez B, Sanchez SS, Escalante F, Carnicero F, Lleonart JB, Gironella M, Martínez R, de la Guia AL, Palomera L, Iglesias R, Ramos FS, de la Serna J, Sanchez PG, Vidal JB, Mateos MV, Morfa MD, Beksac T–M, Vural F, Aydin Y, Unal A, Goker H, Bilgir O, Guvenc B, Turgut M, Ozet GG, Ali R, Masliak Z, Kyselyova M, Glushko N, Vybyrana R, Skrypnyk I, Tretyak N, Kharchevska T, Dyagil I, Popovs'ka T, Shimanskiy V, Lysa T, Oliynyk H, Vilchevskaya K, Kryachok I, Popovych Y, Romanyuk N, Yushchenko N, Kaplan P, Rekhtman G, Pylypenko H, Kozlov V, Mohty M, Terpos E, Mateos MV, Palumbo A, Drach J, Boccadoro M, Harousseau JL, Einsele H, Goldschmidt H, Facon T, Michalet M, Savchenko VG, de la Rubia J, Cook G, Mellqvist UH, Ludwig H (2018) Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study. Clin Lymphoma Myeloma Leuk 18(10):e401–e419. https://doi.org/10.1016/j.clml.2018.06.018 5. Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A, ASPIRE Investigators (2015) Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med 372(2):142–152
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|